Evidence map›Paper›PMID 26032647›Full record

ReviewEnvironmental health perspectives2015

Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation.

Megan R Schwarzman, Janet M Ackerman, Shanaz H Dairkee, Suzanne E Fenton, Dale Johnson, Kathleen M Navarro, Gwendolyn Osborne, Ruthann A Rudel, Gina M Solomon, Lauren Zeise and 1 more

Open access · diamondAbstract readReview
In one paragraph

Review in Environmental health perspectives, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Application of anEnvironmental health perspectives · 2021
    Article
  7. Article
  8. Article
  9. The Mouse Mammary Gland: a Tool to Inform Adolescents About Environmental Causes of Breast Cancer.Journal of cancer education : the official journal of the American Association for Cancer Education · 2020
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Moving forward in carcinogenicity assessment: Report of an EURL ECVAM/ESTIV workshop.Toxicology in vitro : an international journal published in association with BIBRA · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Megan R SchwarzmanCenter for Occupational and Environmental Health, School of Public Health, University of California, Berkeley, Berkeley, California, USA.
Janet M Ackerman
Shanaz H Dairkee
Suzanne E Fenton
Dale Johnson
Kathleen M Navarro
Gwendolyn Osborne
Ruthann A Rudel
Gina M Solomon
Lauren Zeise
Sarah Janssen
California Environmental Protection Agency · USCenter for Environmental Health · USSilent Spring Institute · USCalifornia Pacific Medical Center · USNational Institutes of Health · USNatural Resources Defense Council · USUniversity of California, Berkeley · US

Funding

Mammary Gland as a Sensitive End Point to Effects of Endocrine DisruptorsZIAES102785 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI FENTON, SUZANNE · 2010 to 2021
$38.1M
6 · The paper itself

Abstract

backgroundCurrent approaches to chemical screening, prioritization, and assessment are being reenvisioned, driven by innovations in chemical safety testing, new chemical regulations, and demand for information on human and environmental impacts of chemicals. To conceptualize these changes through the lens of a prevalent disease, the Breast Cancer and Chemicals Policy project convened an interdisciplinary expert panel to investigate methods for identifying chemicals that may increase breast cancer risk.

methodsBased on a review of current evidence, the panel identified key biological processes whose perturbation may alter breast cancer risk. We identified corresponding assays to develop the Hazard Identification Approach for Breast Carcinogens (HIA-BC), a method for detecting chemicals that may raise breast cancer risk. Finally, we conducted a literature-based pilot test of the HIA-BC.

resultsThe HIA-BC identifies assays capable of detecting alterations to biological processes relevant to breast cancer, including cellular and molecular events, tissue changes, and factors that alter susceptibility. In the pilot test of the HIA-BC, chemicals associated with breast cancer all demonstrated genotoxic or endocrine activity, but not necessarily both. Significant data gaps persist.

conclusionsThis approach could inform the development of toxicity testing that targets mechanisms relevant to breast cancer, providing a basis for identifying safer chemicals. The study identified important end points not currently evaluated by federal testing programs, including altered mammary gland development, Her2 activation, progesterone receptor activity, prolactin effects, and aspects of estrogen receptor β activity. This approach could be extended to identify the biological processes and screening methods relevant for other common diseases.

Indexed as

Biological AssayBreast NeoplasmsCarcinogensDNA DamageEstrogensFemaleHumansMutagensPilot ProjectsRiskToxicity TestsCarcinogensEstrogensMutagens

Identifiers

PMID26032647
PMCPMC4671249
OpenAlexW600519270

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.